Rapid identification of novel functional promoters for gene therapy.

Rapid identification of novel functional promoters for gene therapy.

Show other versions (2)

Transcriptional control of transgene expression is crucial to successful gene therapy, yet few promoter/enhancer combinations have been tested in clinical trials. We created a simple, desktop computer database and populated it with promoter sequences from publicly available sources. From this databa...

Full description

Bibliographic Details
Main Authors:	Pringle, I, Gill, DR, Connolly, M, Lawton, A, Hewitt, A, Nunez-Alonso, G, Cheng, S, Scheule, R, Davies, L, Hyde, S
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Rapid identification of novel functional promoters for gene therapy
by: Pringle, I, et al.
Published: (2012)

Rapid identification of novel functional promoters for gene therapy
by: Pringle, I, et al.
Published: (2012)

A novel mixing device for the reproducible generation of nonviral gene therapy formulations.
by: Davies, L, et al.
Published: (2010)

CpG-free plasmid expression cassettes for cystic fibrosis gene therapy
by: Pringle, I, et al.
Published: (2012)

CpG-free plasmid expression cassettes for cystic fibrosis gene therapy.
by: Pringle, I, et al.
Published: (2012)

DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY
by: Gill, DR, et al.
Published: (2010)

The development of gene therapy for diseases of the lung.
by: Gill, DR, et al.
Published: (2004)

Influence of CpG-dinucleotide motifs on the duration of gene expression from plasmid, vectors after in vivo lung delivery
by: Gill, DR, et al.
Published: (2007)

Towards gene therapy for cystic fibrosis: Biodistribution of GL67A/pGM169 DNA and mRNA following aerosol delivery to the mouse lung
by: Pringle, I, et al.
Published: (2008)

Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
by: Pringle, I, et al.
Published: (2009)

Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
by: Davies, L, et al.
Published: (2014)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
by: Davies, G, et al.
Published: (2011)

A PHASE 2B DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NON-VIRAL MEDIATED GENE THERAPY FOR CF
by: Alton, E, et al.
Published: (2013)

The use of CpG-free plasmids to mediate persistent gene expression following repeated aerosol delivery of pDNA/PEI complexes.
by: Davies, L, et al.
Published: (2012)

CONCENTRATED PEI GENE TRANSFER FORMULATIONS RETAIN BIOLOGICAL EFFICACY FOLLOWING LONG-TERM STORAGE AT 4 degrees C
by: Hyde, S, et al.
Published: (2010)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF
by: Davies, J, et al.
Published: (2011)

Identification of transfected cell types following non-viral gene transfer to the murine lung.
by: Davies, L, et al.
Published: (2007)

A novel large animal model for aerosol delivery of gene therapy vectors
by: McLachlan, G, et al.
Published: (2003)

Detection of plasmid DNA vectors following gene transfer to the murine airways.
by: Pringle, I, et al.
Published: (2005)

Progress and prospects: the design and production of plasmid vectors.
by: Gill, DR, et al.
Published: (2009)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
by: Hyde, S, et al.
Published: (2015)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
by: Pringle, I, et al.
Published: (2018)

Model risk : identification, measurement and management /
by: 382501 Scheule, Harald, et al.
Published: (2010)

Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
by: Gill, DR, et al.
Published: (2001)

Optimising non-viral gene delivery in a tumour spheroid model.
by: Mellor, H, et al.
Published: (2006)

Optomising non-viral gene delivery in a tumuor spheroid model
by: Mellor, H, et al.
Published: (2006)

REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
by: Alton, E, et al.
Published: (2012)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
by: Alton, E, et al.
Published: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
by: Alton, E, et al.
Published: (2014)

Transgene sequences free of CG dinucleotides lead to high level, long-term expression in the lung independent of plasmid backbone design
by: Bazzani, R, et al.
Published: (2016)

743. Minicircles are similar to plasmids in providing high level, long-term expression in the lung
by: Gill, D, et al.
Published: (2016)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
by: Alton, E, et al.
Published: (2012)

Update on the UK CF Gene Therapy Consortium Multidoes, non-viral, gene therapy trial
by: Alton, E, et al.
Published: (2012)

Topical delivery of NF-kb decoy related oligodeoxynucleotides reduces pro-inflammatory cytokine response associated with cationic lipid: pDNA vector delivery to murine lungs
by: Varathalingam, et al.
Published: (2004)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
by: Pringle, I, et al.
Published: (2018)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
by: Griesenbach, U, et al.
Published: (2011)

Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice.
by: Davies, L, et al.
Published: (2008)

Gene therapy for pulmonary alveolar proteinosis
by: Atsumi, N, et al.
Published: (2017)

Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung.
by: Pringle, I, et al.
Published: (2007)

Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
by: Meyer-Berg, H, et al.
Published: (2020)